CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-10 | Bowden Christopher Chief Medical Officer | Sale | −1,200 | $86.42 | $104K | 1,724 |
| 2018-07-10 | Bowden Christopher Chief Medical Officer | Sale | −800 | $87.26 | $70K | 924 |
| 2018-07-10 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −2,000 | 93,000 | ||
| 2018-07-09 | Alenson Carman Principal Accounting Officer | Option exercise | +272 | $52.29 | $14K | 272 |
| 2018-07-09 | Alenson Carman Principal Accounting Officer | Sale | −272 | $84.94 | $23K | 0 |
| 2018-07-09 | Alenson Carman Principal Accounting Officer | Option exercise · Stock option (right to buy) | −272 | 12,578 | ||
| 2018-07-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −3,000 | 16,154 | ||
| 2018-07-05 | Biller Scott Chief Scientific Officer | Option exercise | +3,000 | $9.05 | $27K | 60,196 |
| 2018-07-05 | Biller Scott Chief Scientific Officer | Sale | −2,700 | $83.41 | $225K | 57,496 |
| 2018-07-05 | Biller Scott Chief Scientific Officer | Sale | −300 | $84.32 | $25K | 57,196 |
| 2018-07-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock options (right to buy) | +3,000 | 16,154 | ||
| 2018-06-22 | Hoerter Steven L. Chief Commercial Officer | Option exercise | +2,050 | $39.76 | $82K | 2,050 |
| 2018-06-22 | Hoerter Steven L. Chief Commercial Officer | Sale | −2,050 | $97.58 | $200K | 0 |
| 2018-06-22 | Hoerter Steven L. Chief Commercial Officer | Option exercise · Stock option (right to buy) | −2,050 | 64,750 | ||
| 2018-06-14 | Foster-Cheek Kaye I Director | Option exercise | +9,000 | $50.73 | $457K | 11,200 |
| 2018-06-14 | Foster-Cheek Kaye I Director | Sale | −2,181 | $92.62 | $202K | 9,019 |
| 2018-06-14 | Foster-Cheek Kaye I Director | Sale | −5,980 | $93.78 | $561K | 3,039 |
| 2018-06-14 | Foster-Cheek Kaye I Director | Sale | −839 | $94.30 | $79K | 2,200 |
| 2018-06-14 | Foster-Cheek Kaye I Director | Option exercise · Stock option (right to buy) | −9,000 | 0 | ||
| 2018-06-12 | Bowden Christopher Chief Medical Officer | Option exercise | +2,000 | $35.16 | $70K | 2,881 |
Page 59 of 63 · 1,252 trades